FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    33081000077110 un fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    un Is a General adjectival modifier false Inferred relationship Some
    un Is a nombre false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Hydrocodone bitartrate 10 mg and paracetamol 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Hydrocodone bitartrate 5 mg and paracetamol 500 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Hydrocodone bitartrate 7.5 mg and paracetamol 500 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 5 mg and paracetamol 556 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Hydrocodone bitartrate 5 mg and paracetamol 556 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 650 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Hydrocodone bitartrate 10 mg and paracetamol 660 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 750 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 3
    Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Paracetamol 500 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Paracetamol 500 mg and phenyltoloxamine citrate 60 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Paracetamol 250 mg and salicylamide 600 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Paracetamol 250 mg and salicylamide 600 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Isoniazid 150 mg and rifampicin 300 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Isoniazid 150 mg and rifampicin 300 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 3
    Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Pseudoephedrine hydrochloride 60 mg and triprolidine hydrochloride 2.5 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Product containing precisely ropinirole hydrochloride 4 milligram/1 each conventional release oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Butalbital 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Butalbital 50 mg and paracetamol 325 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 2
    Valdecoxib 10 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Valdecoxib 20 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Tacrine 10 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely tacrine 20 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Product containing precisely tacrine 30 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False un Inferred relationship Some 1
    Tacrine 40 mg oral capsule Has presentation strength denominator value False un Inferred relationship Some 1
    Voriconazole 50 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Voriconazole 200 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Secbutabarbital sodium 15 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1
    Secbutabarbital sodium 100 mg oral tablet Has presentation strength denominator value False un Inferred relationship Some 1

    Start Previous Page 22 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start